Suppr超能文献

左心室对大鼠一氧化氮合酶抑制所致慢性压力超负荷的适应性变化

Left ventricular adaptation to chronic pressure overload induced by inhibition of nitric oxide synthase in rats.

作者信息

Matsubara B B, Matsubara L S, Zornoff L A, Franco M, Janicki J S

机构信息

Departmento de Clínica Médica, Faculdade de Medicina de Botucatu-UNESP, Brazil.

出版信息

Basic Res Cardiol. 1998 Jun;93(3):173-81. doi: 10.1007/s003950050084.

Abstract

Recent studies have indicated that chronic inhibition of nitric oxide synthase induces arterial hypertension without myocardial hypertrophy. We investigated the mechanisms of left ventricular (LV) adaptation to this condition. Also, we analyzed the effect of the angiotensin-converting enzyme inhibitor (ACEI), lisinopril, in this experimental model of ventricular pressure overload. Fifty-eight Wistar rats received eight weeks of treatment with either NW-nitro-L-arginine-methyl ester (L-NAME group, n = 19), lisinopril (LISINOPRIL group, n = 19) or the combination of both drugs (LNAMELIS group, n = 20). All results were compared to age and sex matched untreated rats (CONTROL group, n = 18). Tail-cuff blood pressure rose significantly in L-NAME treated rats (195 +/- 29 mm Hg) compared to the CONTROL (141 +/- 12 mm Hg), LISINOPRIL (97 +/- 13 mm Hg), and LNAMELIS (113 +/- 16 mm Hg) groups. There was no myocardial hypertrophy in the chronically hypertensive rats. The ventricular unstressed volume was significantly reduced in the L-NAME group (0.119 +/- 0.027 mL) compared to the CONTROL (0.158 +/- 0.026 mL) indicating a disproportional reduction in ventricular volume related to the myocardial mass. The chamber size modification resulted in a systolic stress which was comparable to the CONTROL even though the isovolumetric systolic pressure was higher. The systolic functional data indicated preserved myocardial contractility in L-NAME. LV compliance was increased in the LISINOPRIL group and myocardial passive stiffness was lower in all treated rats compared to CONTROL. We conclude that LV. adaptation to chronic pressure overload without hypertrophy involves changes in chamber geometry and myocardial diastolic mechanical properties. Also, ACEI fully prevents L-NAME induced hypertension, reduces myocyte cross-sectional area, and myocardial passive stiffness. The combination of L-NAME plus lisinopril decreases the load independent index of myocardial contractility.

摘要

近期研究表明,慢性抑制一氧化氮合酶可诱发动脉高血压,但不会导致心肌肥大。我们研究了左心室(LV)适应这种情况的机制。此外,我们分析了血管紧张素转换酶抑制剂(ACEI)赖诺普利在这种心室压力超负荷实验模型中的作用。58只Wistar大鼠接受了为期8周的治疗,分别给予Nω-硝基-L-精氨酸甲酯(L-NAME组,n = 19)、赖诺普利(赖诺普利组,n = 19)或两种药物联合使用(LNAMELIS组,n = 20)。所有结果均与年龄和性别匹配的未治疗大鼠(对照组,n = 18)进行比较。与对照组(141±12 mmHg)、赖诺普利组(97±13 mmHg)和LNAMELIS组(113±16 mmHg)相比,L-NAME治疗的大鼠尾袖血压显著升高(195±29 mmHg)。慢性高血压大鼠未出现心肌肥大。与对照组(0.158±0.026 mL)相比,L-NAME组的心室无应力容积显著降低(0.119±0.027 mL),表明心室容积与心肌质量不成比例地减少。尽管等容收缩压较高,但腔室大小的改变导致收缩期应力与对照组相当。收缩功能数据表明L-NAME组心肌收缩力保持不变。与对照组相比,赖诺普利组左心室顺应性增加,所有治疗组大鼠的心肌被动僵硬度均降低。我们得出结论,左心室适应慢性压力超负荷而无肥大涉及腔室几何形状和心肌舒张力学特性的改变。此外,ACEI可完全预防L-NAME诱导的高血压,减少心肌细胞横截面积和心肌被动僵硬度。L-NAME加赖诺普利的联合使用降低了心肌收缩力的负荷无关指数。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验